| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d78a1a23dbbafd45a8ab8c03106c0ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_494981811887c035eeb4aa86f26c8536
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfcc0434437a0e71a92954099ea5948b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0bc3ace64986ff553483bccd9aa12cb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6135fe92b5244c3a7e7656706a25ff33 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-57 |
| filingDate |
2011-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fad26b8fd7153fd5663c148568e9acaa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12ff170ef7362b38d4cee70ad9e95ea2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31ea83cea9ec198acfbeeb7ca47ee788
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78d0063e021b9a5219849a3b211c82ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b5941afbda94fff0ad5a77b6e099310 |
| publicationDate |
2011-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011218325-A1 |
| titleOfInvention |
Inhibitor of Endogenous Human Interferon-Gamma |
| abstract |
Inactivated protein derivatives of the hIFN-γ that preserve affinity to the hIFN-γ receptor are useful in the treatment of autoimmune diseases, especially multiple sclerosis. |
| priorityDate |
2005-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |